Literature DB >> 31772829

Imaging Artifacts and Segmentation Errors With Wide-Field Swept-Source Optical Coherence Tomography Angiography in Diabetic Retinopathy.

Ying Cui1,2, Ying Zhu1,3, Jay C Wang1, Yifan Lu4, Rebecca Zeng1,5, Raviv Katz1, David M Wu1, Demetrios G Vavvas1, Deeba Husain1, Joan W Miller1, Leo A Kim1, John B Miller1.   

Abstract

PURPOSE: To analyze imaging artifacts and segmentation errors with wide-field swept-source optical coherence tomography angiography (SS-OCTA) in diabetic retinopathy (DR).
METHODS: We conducted a prospective, observational study at Massachusetts Eye and Ear from December 2018 to March 2019. Proliferative diabetic retinopathy (PDR), nonproliferative diabetic retinopathy (NPDR), diabetic patients with no diabetic retinopathy (DR), and healthy control eyes were included. All patients were imaged with a SS-OCTA and the Montage Angio (15 × 9 mm) was used for analysis. Images were independently evaluated by two graders using the motion artifact score (MAS). All statistical analyses were performed using SPSS 25.0 and R software.
RESULTS: One hundred thirty-six eyes in 98 participants with the montage image were included in the study. Patients with more severe stages of DR had higher MAS by trend test analysis (P < 0.05). The occurrence of segmentation error was 0% in the healthy group, 10.53% in the no DR group, 10.00% in the NPDR group, and 50% in the PDR group. Multivariate regression analysis showed that the severity of DR and dry eye were the major factors affecting MAS (P < 0.05). There were some modifiable artifacts that could be corrected to improve image quality.
CONCLUSIONS: Wide field SS-OCTA assesses retinal microvascular changes by noninvasive techniques, yet distinguishing real alterations from artifacts is paramount to accurate interpretations. DR severity and dry eye correlated with MAS. TRANSLATIONAL RELEVANCE: Understanding contributing factors and methods to reduce artifacts is critical to routine use and clinical trial with wide-field SS-OCTA. Copyright 2019 The Authors.

Entities:  

Keywords:  artifact; diabetic retinopathy; optical coherence tomography angiography; segmentation error; wide field

Year:  2019        PMID: 31772829      PMCID: PMC6859832          DOI: 10.1167/tvst.8.6.18

Source DB:  PubMed          Journal:  Transl Vis Sci Technol        ISSN: 2164-2591            Impact factor:   3.283


Introduction

As optical coherence tomography angiography (OCTA) becomes more widely available in clinical practice, it is important to understand the advantages and limitations of this emerging modality.[1] The vascular changes of diabetic retinopathy (DR) have been well characterized with OCTA.[2] OCTA has the advantage of resolving more structural details of many microvascular abnormalities than fluorescein angiography (FA), such as the foveal avascular zone (FAZ) enlargement and irregularity, capillary nonperfusion, intraretinal microvascular abnormalities (IRMA), and preretinal neovascularization (NV).[3,4] Furthermore, OCTA can separately detect the superficial capillary and the deep capillary plexus (DCP) that generally are overlaid and seem fused in standard angiographies.[5] With the advent of wide-field swept-source OCTA (SS-OCTA), OCTA shows the potential to replace FA in the diagnosis and monitoring of DR.[6-8] However, imaging artifacts remain common in OCTA, which can lead to inaccuracies and limit its utility.[9] Assessing the quality of OCTA images is essential when using OCTA for the diagnosis and monitoring of DR. Artifacts can arise from poor patient cooperation, media opacity, optical aberrations, and machine-related segmentation errors. It is of great importance to analyze and understand motion artifacts and segmentation errors before performing further qualitative and quantitative analysis with OCTA images. However, few studies[9-11] on artifacts and segmentation errors have been carried out, especially in DR using wide-field SS-OCTA. The aim of our study was to specifically evaluate wide-field SS-OCTA image quality, artifacts, and segmentation errors in DR, as well as to investigate the major factors affecting image quality. In addition, we share our experience using wide field SS-OCTA and experiences to maximize image quality and minimize image artifacts.

Methods

Subjects

We conducted a prospective, observational study at Massachusetts Eye and Ear (MEE) from December 2018 to March 2019. Proliferative DR (PDR), nonproliferative DR (NPDR), diabetic patients with no DR, and healthy control eyes with no ocular diseases were included. Exclusion criteria included eyes with concomitant retinal diseases, severe media opacities, signal strength index (SSI) less than seven using the default settings of the instrument, and low image quality preventing creation of a montage image automatically by the device. This study was approved by the institutional review board of MEE and informed consent was obtained from all subjects. All procedures adhered to the tenets of the Declaration of Helsinki and Health Insurance Portability and Accountability Act regulations.

Swept-Source OCTA

For each visit, all participants underwent ophthalmic examination, including Snellen best-corrected visual acuity (BCVA), slit-lamp examination, intraocular pressure, and dilated fundus examination. All subjects were imaged with a 100-kHz SS-OCTA instrument (Plex Elite 9000; Carl Zeiss Meditec Inc., Dublin, CA) that uses a laser at a central wavelength of 1060 nm with a bandwidth of 100 nm.[12] We used the Montage Angio (15 mm × 9 mm; 2-scan composite) as the primary scan protocol. The montage image was obtained by combining separate superior and inferior 15 × 9-mm scans into a single image with a field of view (FOV) greater than 50° centered on the fovea. The Angio 15 × 9-mm scans used 500 A-scans per B-scan, resulting in an A- and B-scan separation of 24 μm. After a quality check 15 × 9-mm images were montaged using the automatic montage export function available on the device. Vascular layers were segmented automatically using the built-in custom segmentation of the device. The vitreoretinal interface (VRI) slab was defined with an inner boundary of 300 μm above the internal limiting membrane (ILM) and an outer boundary of 30 μm below the ILM. The superficial capillary plexus (SCP) extended from the ILM to the inner plexiform layer (IPL), and the DCP from the IPL to the outer plexiform layer (OPL). The choriocapillaris (CC) extended from 29 μm beneath the retinal pigment epithelium (RPE) to 49 μm beneath the RPE, and the choroidal layer had a thickness of 51 μm and extended from 64 to 115 μm below Bruch's membrane.[13] The different layers were color-coded as follows: VRI as purple, SCP as red, and DCP as green.

Evaluation for Artifacts and Segmentation Errors

The classification and detailed definition for artifacts[9,14] in montage OCTA images were summarized in Table 1. The motion artifact score (MAS) is a grading system used to quantify motion artifact. The grading criterion for MAS was based on a previous study[10] and revised according to the characteristics of montage images (Table 2). A higher MAS reflects more artifacts and lower image quality. Motion artifacts caused by eye movement or software correction of eye movement (stretching, displacement, vessel doubling) were all included in MAS to systematically evaluate image quality. The SCP was used for the evaluation of MAS because it included the large landmark vessels of the superficial plexus and was free from projection artifacts. Due to signal loss in the periphery of the image, only the area within 7 mm of the fovea was evaluated. Demographic data, clinical data regarding diabetes, as well as dry eye diagnoses derived from medical records influencing patients' fixation ability were taken into consideration as possible factors related to image quality in regression analysis.
Table 1

Classification and Definition of Artifacts in OCTA Montage Images

Classification
Artifacts
Definition
Systemic artifactsProjection artifactVascular structures of superficial layers were mistakenly shown in deeper layers.
MaskingMedia opacity or certain lesions (e.g., macular edema, PED) caused signal loss in underlying layers.
UnmaskingSignal loss in certain areas (e.g., retinal or RPE atrophy) lead to signal enhancement in underlying layers.
Loss of signalAppeared as a localized area of signal loss on the en face image due to loss of scan focus, more common in eyes with tumor, high myopia, or hyperopia, partially operator-dependent.
Image processing and display (depend on the type of device)Segmentation artifactA deviation of the certain slab caused by errors in (automatic) segmentation.
Duplication of vesselsDefined as two copies of each blood vessel in the en face image caused by software correction of eye motion.
Alignment errorThe superior and inferior part of the montage image appeared to be of different depth, possibly due to projection removal
Artifacts caused by movementDisplacementVery thin vertical lines leading to an apparent interruption or displacement of the vessels caused by eye movements.
Blink artifactA region of lost image information related to eye movement. It appears as an end-to-end black line of varying width through all depths of en face scans.
Stretch artifactShort strips of different brightness at the edge of OCTA shots.
Table 2

Revised SS-OCTA MAS (Score 1–6)

Score
Definition
1No or slight displacement, absence of all other artifacts due to motion or software correction
2Slight or moderate displacement, nonsignificant black line
3Significant displacement, vessel doubling, stretch artifacts or nonsignificant black line in one quadrant
4Significant displacement, vessel doubling, stretch artifacts, or nonsignificant black line in two quadrants
5Significant displacement, vessel doubling, stretch artifacts, or significant black line in one quadrant
6Significant displacement, vessel doubling, or stretch artifacts or significant black line in two quadrants
Classification and Definition of Artifacts in OCTA Montage Images Revised SS-OCTA MAS (Score 1–6) The occurrence of segmentation errors in all layers was evaluated for each montage image. If segmentation deviated from the correct plane by more than 50 μm, it was defined as inaccurate.[15] Segmentation errors due to artifacts were excluded from the evaluation of segmentation accuracy. The machine provided a default SSI for each image, which was used as an initial evaluation of image quality. Wide-field OCTA images were independently evaluated for the artifacts and segmentation errors by two independent experienced ophthalmologists (YC and YZ), at different timepoints and in different orders. A third trained grader (JBM) adjudicated in cases of discrepancy. All images were evaluated on the instrument display screen in a standardized, dimmed environment.

Statistical Analysis

Statistical analyses were performed using SPSS version 25.0 (IBM Corporation, Somers, NY, USA) and R software (the R Foundation for Statistical Computing, Vienna, Austria). Normally distributed continuous variables were presented as mean ± standard deviation, and nonnormally distributed continuous data were presented as median (interquartile range [IQR]). Differences between groups were compared using mixed-model analysis (normally distributed variables) or Clustered Wilcoxon rank sum test (nonnormally distributed variables), as appropriate. Trend test analysis was used to assess the association between the severity of DR and MAS. Considering the inclusion of both eyes of the same participants, univariable and multilevel mixed-effect linear models were performed to determine clinical factors associated with SSI of OCTA images. Intergrader reproducibility was assessed by Cohen's kappa coefficient. A 2-tailed P value of less than 0.05 was considered statistically significant for all analysis.

Results

Demographic Data

One hundred thirty-six eyes (48 eyes with PDR, 40 eyes with NPDR, 19 eyes of diabetic patients without DR, and 29 healthy eyes) in 98 participants with montage images were included in the study (Table 3). The average age of the participants was 55.49 ± 13.77 years, and there was no significant difference in age among the four groups (P = 0.759). Seventy-one patients with DM were included, of which 13 (18.3%) had type 1 diabetes mellitus (T1DM). Median logMAR BCVA was 0.04 (0, 0.18), with the worst being 0.70 (20/100 Snellen equivalent) in a PDR patient.
Table 3

Demographic Data of Participants

Parameter
Value
Participants (eyes)98 (136)
Age, y mean ± SD55.49 ± 13.77
Sex (participants), n (%)
 Male47 (48.0)
 Female51 (52.0)
Type of diabetes (participants)a71
 T1DM, n (%)13 (18.3)
 T2DM, n (%)58 (81.7)
Duration of diabetes (years)a, n (IQR)16.0 (10.0, 27.0)
HbA1c, %a, mean ± SD8.07 ± 1.74
Groups (severity of DR, eyes), n (%)
 Healthy eye29 (21.3)
 No DR in DM patients19 (14.0)
 NPDR40 (29.4)
 PDR48 (35.3)
Involved eye, n (%)
 Right74 (54.4)
 Left62 (45.6)
BCVA (LogMAR), n (IQR)0.04 (0, 0.18)
Dry eye (eyes), n (%)15 (11.0)

HbA1c, glycosylated hemoglobin.

All healthy participants were excluded from the statistical analysis of diabetes related parameters (e.g., duration of diabetes, HbA1c).

Demographic Data of Participants HbA1c, glycosylated hemoglobin. All healthy participants were excluded from the statistical analysis of diabetes related parameters (e.g., duration of diabetes, HbA1c).

Characteristics of Artifacts in Montage Images

Representative images of artifacts in montage images with corresponding MAS are shown in Figure 1. The Angio 15 × 9-mm image was composed of vertical scans from top to bottom, so the motion artifacts caused by eye movement were vertical. Alignment error, an artifact specific to montage images, arises from image processing. It only occurs in the retinal-depth encoded image with superior and inferior parts of the montage image appearing to be of different depth, possibly due to projection removal (Fig. 2). In our study, alignment error was observed in 18 eyes (13.24%) in montage 15 × 9-mm Angio image after removing projection and no statistical difference was detected across groups (P = 0.293).
Figure 1

Representative images for MAS Grading. (A) MAS 1 with no obvious artifacts. (B) MAS 3 with significant displacement (arrow head) and nonsignificant black lines (narrow arrow) in one quadrant. (C) MAS 4 with significant displacement (arrow head) and vessel doubling (*) in two quadrants, no significant black lines. (D) MAS 5 with significant black lines (wide arrow) in one quadrant.

Figure 2

Alignment error. Both retinal-depth encoded (A, C) and DCP (B, D) montage images before (A, B) and after projection removal (C, D) are shown here. After projection removal, the upper and lower part of retinal-depth encoded montage image (C) appeared to be of different depth, which was defined as “alignment error.”

Representative images for MAS Grading. (A) MAS 1 with no obvious artifacts. (B) MAS 3 with significant displacement (arrow head) and nonsignificant black lines (narrow arrow) in one quadrant. (C) MAS 4 with significant displacement (arrow head) and vessel doubling (*) in two quadrants, no significant black lines. (D) MAS 5 with significant black lines (wide arrow) in one quadrant. Alignment error. Both retinal-depth encoded (A, C) and DCP (B, D) montage images before (A, B) and after projection removal (C, D) are shown here. After projection removal, the upper and lower part of retinal-depth encoded montage image (C) appeared to be of different depth, which was defined as “alignment error.”

SSI, MAS, and Segmentation Errors in Montage OCTA Images

SSI and MAS across different groups were summarized in Table 4. There were statistically significant differences in SSI and MAS between healthy, no DR, NPDR, and PDR groups (P < 0.001). Patients with higher severity of DR had a significantly higher MAS (P < 0.05, trend test analysis). Compared with the superior part of the image, MAS in the inferior part was significantly higher in each group (P < 0.05). The quality of Angio image 15 × 9 mm in the inferior part was worse than that in the superior part.
Table 4

SSI and MAS In Different Groups

Groups (Eyes)
Healthy (29)
No DR (19)
NPDR (40)
PDR (48)
P Value
Age53.14 ± 13.1755.58 ± 10.9056.65 ± 15.8954.50 ± 13.640.759
BCVA, median (IQR)0 (−0.05, 0.05)0.04 (0, 0.14)0.02 (0, 0.18)0.14 (0.04, 0.22)<0.001
SSI, mean ± SD
 Superior8.79 ± 0.499.00 ± 0.588.68 ± 0.768.44 ± 0.770.017
 Inferior8.76 ± 0.649.05 ± 0.628.55 ± 0.648.33 ± 0.780.001
 Average8.78 ± 0.519.03 ± 0.518.61 ± 0.578.39 ± 0.720.001
MAS, mean ± SD
 Superior1.48 ± 0.691.89 ± 0.742.78 ± 1.543.02 ± 1.73<0.001
 Inferior1.79 ± 1.012.11 ± 1.942.80 ± 1.623.40 ± 1.35<0.001
 Average1.64 ± 0.711.97 ± 1.082.79 ± 1.403.21 ± 1.35<0.001
SSI and MAS In Different Groups Segmentation errors were absent in healthy eyes and occurred in 10.53% eyes of no DR group and 10.00% eyes of NPDR group. The highest occurrence of segmentation errors was in the inferior part in eyes of PDR group (50.0%). Segmentation errors were mostly observed in DR patients with NV, epiretinal membrane (ERM), diabetic macular edema (DME), and pigment epithelium detachment (PED). ILM and IPL were the segmentation boundaries most prone to segmentation errors in all DR patients compared with the OPL and RPE (Fig. 3).
Figure 3

Representative OCTA images. Retinal-depth encoded (A, B), SCP (C, D), representative B scan showing segmentation error due to NV (E, F) for follow-ups of a PDR patient. The patient first presented with blurry vision 1 month after panretinal photocoagulation (A, C, E) and experienced significant progression at 1-month follow-up (B, D, F). The images at follow-up were taken with small pupil and had more artifacts compared with the first visit.

Representative OCTA images. Retinal-depth encoded (A, B), SCP (C, D), representative B scan showing segmentation error due to NV (E, F) for follow-ups of a PDR patient. The patient first presented with blurry vision 1 month after panretinal photocoagulation (A, C, E) and experienced significant progression at 1-month follow-up (B, D, F). The images at follow-up were taken with small pupil and had more artifacts compared with the first visit. For interobserver reproducibility, we chose the MAS of the superior part in the NPDR group as the primary parameter to test. The MAS evaluated by two graders was 2.75 ± 1.50 and 2.80 ± 1.55, respectively by paired sample t-test (P = 0.481). The concordance correlation coefficient was 0.996 (P < 0.01).

Factors Related to Image Quality

Univariate and multivariate regression analysis revealed that eyes with more severe stage of DR or older age had lower SSI (P < 0.05) (Table 5). Furthermore, eyes with more severe stages of DR or dry eye had higher MAS (P < 0.05) (Table 6).
Table 5

Univariate and Multivariate Regression Analysis for SSI

Parameter
SSI Average (Univariate)
SSI Average (Multivariate)
B (95%CI)
P
B (95%CI)
P
Age (per 10 y)−0.09 (−0.17, −0.02)0.018−0.09 (−0.16, −0.01)0.019
DM duration (per 10 y)−0.10 (−0.19, −0.01)0.036
BCVA, LogMAR−0.77 (−1.54, −0.01)0.048
Severity of DR (groups)−0.16 (−0.25, −0.07)0.001−0.15 (−0.24, −0.06)0.001
DME−0.30 (−0.54, −0.06)0.014
Dry eye−0.48 (−0.82, −0.14)0.006
Table 6

Univariate and Multivariate Regression Analysis for MAS

Parameter
MAS Total (Univariate)
MAS Total (Multivariate)
B (95%CI)
P
B (95%CI)
P
Age (per 10 y)0.17 (0.01, 0.34)0.0410.07 (−0.09, 0.23)0.412
Sex (male vs. female )0.11 (−0.35, 0.57)0.6450.05 (−0.36, 0.46)0.804
DM duration (>12 years vs. ≤12)0.60 (0.12, 1.09)0.015
BCVA, LogMAR2.70 (1.10, 4.29)0.0011.29 (−0.32, 2.90)0.115
Severity of DR (groups)0.54 (0.36, 0.72)<0.0010.42 (0.22, 0.61)<0.001
DME0.86 (0.36, 1.36)0.001
Dry eye (yes vs. no)1.45 (0.75, 2.14)<0.0011.07 (0.40, 1.75)0.002
Univariate and Multivariate Regression Analysis for SSI Univariate and Multivariate Regression Analysis for MAS However, there were also some factors (e.g., the size of pupil, head position of the examinee, adjustment of focus) that could be corrected to reduce modifiable artifacts. Figure 3 showed OCTA images of the PDR patient in two visits. Images taken with a small pupil had more artifacts in the second visit. Though the young patient cooperated well, more artifacts, especially in the periphery were observed compared with the first visit. In Figure 4, a comparison of image quality before and after head position adjustment were displayed.
Figure 4

Representative OCTA images before (A) and after (B) head position adjustment. Once the chin or the forehead is not adhered to the machine, the image (A) will lose signal in the periphery and show artifacts. After head position adjustment, the image (B) was free of artifacts.

Representative OCTA images before (A) and after (B) head position adjustment. Once the chin or the forehead is not adhered to the machine, the image (A) will lose signal in the periphery and show artifacts. After head position adjustment, the image (B) was free of artifacts.

Discussion

The present study focused on the analysis of motion artifacts and segmentation errors in wide-field OCTA images of diabetic patients. We listed common motion artifacts and described alignment error (an artifact specific to montage images) in detail. We found that patients with higher severity of DR had a higher MAS and segmentation errors were more frequent in eyes with PDR. Because wide-field SS-OCTA has been used in the diagnosis and follow-up of DR,[2,7,8,12,16] it is necessary to understand the factors that contribute to both segmentation and motion artifacts of montage images in order to ensure meaningful and reliable results. This is particularly important to accurately incorporate wide-field OCTA into our clinical decision making in DR patients as we examine small, quantitative differences in NV and nonperfusion areas. This study was the first to describe artifacts and segmentation errors in wide-field SS-OCTA. Compared with conventional 6 × 6-mm images, capturing the Angio 15 × 9-mm image involves several of the following additional considerations: (1) due to the longer acquisition time, fixation loss occurs more frequently resulting in more artifacts, especially in the periphery; (2) the curvature of the eye makes it difficult to keep in focus the long 15-mm scan span for the montage image throughout acquisition so loss of signal is more frequent than conventional, shorter scans; and (3) the Angio 15 × 9-mm image was composed of vertical scans from top to bottom, so the motion artifacts caused by eye movement were vertical. We chose the montage 15 × 9-mm angio image as the scanning protocol for the following reasons: (1) most vascular abnormalities due to DR were located around the vascular arcades, which are easily captured by the montage images, and are more comparable to conventional FA, and (2) compared with montage (12 × 12 mm; 5-scan composite) Angio images, our scan protocol requires less exam time and better patient cooperation, which translates to fewer artifacts. Though the montage 12 × 12-mm angio images could provide more information about the nasal periphery, a previous study showed that DR vascular abnormalities were more frequent in the temporal fields compared with the nasal fields (P < 0.0001).[17] The OCTA images with higher MAS score limited the ability to visualized fine capillary vessels and DR features. It may be difficult to grade DR severity level and figure out the boundary of nonperfusion area with MAS score of in Montage 15 × 9-mm OCTA image with MAS score of five and six. There are several artifacts assessed in this study, some of which have been previously described, especially systematic artifacts and artifacts caused by movement.[10,14,18] However, the key point of the current study was to focus on artifacts in DR, in which we found a significant correlation between MAS and DR severity as well as dry eye in multivariate regression analysis. People with diabetes are more prone to suffer from dry eye than those without diabetes.[19,20] Dry eye could increase the patient's blink frequency significantly and interfere with image acquisition.[21] The fact that BCVA was not correlated with MAS in multivariate regression analysis might be due to the following factors: (1) BCVA is an important factor contributing to patients' fixation ability; however, there are also other factors we need to consider (e.g., fixation loss, dry eye and the age of patients). The longer scan time is a challenge for patient's attention and some patients tend to lose fixation when they are tired. It also magnifies the effect of abnormality in ocular surface because more blinking will prolong the scan time, which makes a vicious circle; (2) we excluded eyes with SSI less than seven using the default settings of the instrument, and low image quality preventing creation of a montage image automatically by the device. According to the results, the worst BCVA of our included eyes was 20/100. It is possible eyes with worse BCVA were excluded from our analysis due to poor image quality. When patients have relatively good BCVA, other factors impacting their fixation ability might play a more important role. We found an interesting phenomenon that the inferior part of montage image had a higher MAS compared with the superior part. We suppose it might be related to the following: (1) the default setting of the machine performing montage image scan was to do the superior Angio 15 × 9-mm scan first and the inferior Angio 15 × 9-mm scan after. It is not rare to see patient cooperation become worse when doing the inferior part scan. We will do an analysis about the effect of scan order on artifacts in the future, and (2) it is well-recognized that blinking and eyelid dynamics play important roles in the distribution of tears. Tear film break-up in healthy subjects was typically inferior.[22] In the long process of scanning, reduced and incomplete blinking along with increased tear film break-up may explain the worse imaging quality of the inferior part. Furthermore, we described a montage-specific artifact “alignment error,” which was different from focus artifact described by Tomlinson et al.[23] It is related to image processing, in particular projection artifact removal. In fact, the retinal-depth encoded image could appear normal if one chose not to remove projection artifacts. Incorrect segmentation results in anatomically incorrect en face OCTA images and consequently inaccurate quantification of vessel parameters in DR. Compared with conventional 6 × 6-mm images, the montage image covers a much larger area so any segmentation errors could also be magnified. In PDR patients, large areas of NV could lead to significant segmentation errors in the VRI and superficial retina slabs (Fig. 3), which often underestimated the size of the NV. DME can also cause segmentation errors in the DCP and interfere with the quantification analysis of vessel density. Fortunately, segmentation errors can be manually corrected by editing each segmentation line (ILM, IPL, OPL, RPE, RPE-fit) and then automatically propagating the changes, which applies the newly defined layer to all B-scans included in the scan. The correction of segmentation was critical to distinguish IRMA and NVE, which is of great value in the diagnosis of early PDR. Therefore, for DR patients with NV, ERM, DME, and PED, care should be taken with segmentation errors and manual correction should be done accordingly to avoid misinterpretation of images. One purpose of analyzing artifacts and segmentation errors was to identify ways to obtain higher quality images. Artifacts can be classified as unmodifiable and modifiable, and the latter was the focus for image-quality improvement. Though the use of eye-tracking technology could significantly decrease motion artifacts,[24] operator skill and patient cooperation still play an important role in obtaining a good image. This is especially true in wide-field OCTA because acquisition time is longer than conventional OCTA scans. Before imaging a patient, systemic and ocular evaluation should be performed to prepare the operator for possible difficulties. Patients with ocular conditions (e.g., nystagmus, ptosis, media opacity[25]) and some systemic diseases (e.g., Parkinson's disease, multiple sclerosis[26]) could substantially undermine image qualities. We suggest the following tips to help reduce modifiable artifacts with the wide-field SS-OCTA system used in the present study: (1) focus should be constantly adjusted to make good visibility of the retinal blood vessels sharp and clear during the long scan. We can use manual adjustment when the patient is not well positioned, with hyperopia or high myopia; (2) keep head position stable is an essential way to avoid the motion artifacts; (3) it is possible to ask the patient to rotate the eye or adjust the eye alignment subtly by moving the chinrest settings to reduce the effect of small areas of vitreous opacity on image quality; and (4) dilation, using fixation light, rest between scans, blink during the scan and application of artificial tears are also helpful to get better OCTA images. The present study is the first to investigate artifacts in wide-field SS-OCTA and provide some experience in obtaining higher quality montage images in DR patients. Some limitations of this study include the following: (1) though we described some systemic artifacts (projection artifacts, masking, unmasking, and loss of signal), image processing artifacts, they were not included in the statistical analysis for image quality; (2) the ocular surface condition was not evaluated with objective investigations and all dry eye diagnoses were derived from medical records; (3) the lens status was not included in the correlation analysis; and (4) acquisition time of Angio 15 × 9-mm image was not evaluated. In conclusion, both motion artifacts and segmentation errors are frequent in eyes with PDR using wide-field OCTA. It is necessary to assess these image artifacts in montage images in order to obtain meaningful and reliable results, especially in DR patients with DME, NV, PED, or ERM. As OCTA and wider scanning patterns become more common in DR clinical trials, identifying methods to improve image quality and reduce artifacts will be required to maximize the clinical application of this evolving, yet insightful OCTA technology.
  26 in total

1.  Evaluation of artifacts associated with macular spectral-domain optical coherence tomography.

Authors:  Ian C Han; Glenn J Jaffe
Journal:  Ophthalmology       Date:  2010-02-19       Impact factor: 12.079

2.  Blinking and tear break-up during four visual tasks.

Authors:  Nikole L Himebaugh; Carolyn G Begley; Arthur Bradley; Jenni A Wilkinson
Journal:  Optom Vis Sci       Date:  2009-02       Impact factor: 1.973

3.  Image Artifacts in Optical Coherence Tomography Angiography Among Patients With Multiple Sclerosis.

Authors:  Mustafa Iftikhar; Sidra Zafar; Natalia Gonzalez; Olwen Murphy; M S Ohemaa Kwakyi; B S Sydney Feldman; Peter A Calabresi; Shiv Saidha; Roomasa Channa
Journal:  Curr Eye Res       Date:  2019-01-28       Impact factor: 2.424

4.  QUANTIFICATION OF RETINAL CAPILLARY NONPERFUSION IN DIABETICS USING WIDE-FIELD OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY.

Authors:  A Yasin Alibhai; Lucas R De Pretto; Eric M Moult; Chris Or; Malvika Arya; Mitchell McGowan; Oscar Carrasco-Zevallos; ByungKun Lee; Siyu Chen; Caroline R Baumal; Andre J Witkin; Elias Reichel; Anderson Zanardi de Freitas; Jay S Duker; James G Fujimoto; Nadia K Waheed
Journal:  Retina       Date:  2020-03       Impact factor: 4.256

5.  Characteristics of Neovascularization in Early Stages of Proliferative Diabetic Retinopathy by Optical Coherence Tomography Angiography.

Authors:  Neha Chowdhary; Ankita Shrivastav; Vikram Vinayak Koundanya; Rahul Mayor; Shalini Singh; Manisha Agarwal
Journal:  Am J Ophthalmol       Date:  2018-10-05       Impact factor: 5.258

6.  IMAGE QUALITY AND ARTIFACTS ON OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY: Comparison of Pathologic and Paired Fellow Eyes in 65 Patients With Unilateral Choroidal Melanoma Treated With Plaque Radiotherapy.

Authors:  Emil A T Say; Sandor Ferenczy; George N Magrath; Wasim A Samara; Chloe T L Khoo; Carol L Shields
Journal:  Retina       Date:  2017-09       Impact factor: 4.256

7.  Longitudinal Wide-Field Swept-Source OCT Angiography of Neovascularization in Proliferative Diabetic Retinopathy after Panretinal Photocoagulation.

Authors:  Jonathan F Russell; Yingying Shi; John W Hinkle; Nathan L Scott; Kenneth C Fan; Cancan Lyu; Giovanni Gregori; Philip J Rosenfeld
Journal:  Ophthalmol Retina       Date:  2018-11-24

8.  Peripheral lesions identified by mydriatic ultrawide field imaging: distribution and potential impact on diabetic retinopathy severity.

Authors:  Paolo S Silva; Jerry D Cavallerano; Jennifer K Sun; Ahmed Z Soliman; Lloyd M Aiello; Lloyd Paul Aiello
Journal:  Ophthalmology       Date:  2013-06-15       Impact factor: 12.079

9.  OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY FEATURES OF DIABETIC RETINOPATHY.

Authors:  Thomas S Hwang; Yali Jia; Simon S Gao; Steven T Bailey; Andreas K Lauer; Christina J Flaxel; David J Wilson; David Huang
Journal:  Retina       Date:  2015-11       Impact factor: 4.256

Review 10.  Optical Coherence Tomography Angiography.

Authors:  Simon S Gao; Yali Jia; Miao Zhang; Johnny P Su; Gangjun Liu; Thomas S Hwang; Steven T Bailey; David Huang
Journal:  Invest Ophthalmol Vis Sci       Date:  2016-07-01       Impact factor: 4.799

View more
  12 in total

Review 1.  Widefield Optical Coherence Tomography Angiography in Diabetic Retinopathy.

Authors:  Alessia Amato; Francesco Nadin; Federico Borghesan; Maria Vittoria Cicinelli; Irini Chatziralli; Saena Sadiq; Rukhsana Mirza; Francesco Bandello
Journal:  J Diabetes Res       Date:  2020-11-24       Impact factor: 4.011

2.  Comparison Between Graders in Detection of Diabetic Neovascularization With Swept Source Optical Coherence Tomography Angiography and Fluorescein Angiography.

Authors:  Hasenin Al-Khersan; Jonathan F Russell; Thomas A Lazzarini; Nathan L Scott; John W Hinkle; Nimesh A Patel; Nicolas A Yannuzzi; Benjamin J Fowler; Rehan M Hussain; Anita Barikian; Jayanth Sridhar; Stephen R Russell; Luis J Haddock; William E Smiddy; Seenu M Hariprasad; Yingying Shi; Liang Wang; William Feuer; Giovanni Gregori; Philip J Rosenfeld
Journal:  Am J Ophthalmol       Date:  2020-12-11       Impact factor: 5.258

Review 3.  Artifacts in Optical Coherence Tomography Angiography.

Authors:  Pasha Anvari; Maryam Ashrafkhorasani; Abbas Habibi; Khalil Ghasemi Falavarjani
Journal:  J Ophthalmic Vis Res       Date:  2021-04-29

4.  Widefield Swept-Source OCT Angiography Metrics Associated with the Development of Diabetic Vitreous Hemorrhage: A Prospective Study.

Authors:  Ying Cui; Ying Zhu; Edward S Lu; Rongrong Le; Inês Laíns; Raviv Katz; Jay C Wang; Itika Garg; Yifan Lu; Rebecca Zeng; Dean Eliott; Demetrios G Vavvas; Deeba Husain; Joan W Miller; Leo A Kim; David M Wu; John B Miller
Journal:  Ophthalmology       Date:  2021-02-26       Impact factor: 14.277

5.  Comparison of widefield swept-source optical coherence tomography angiography with ultra-widefield colour fundus photography and fluorescein angiography for detection of lesions in diabetic retinopathy.

Authors:  Ying Cui; Ying Zhu; Jay C Wang; Yifan Lu; Rebecca Zeng; Raviv Katz; Filippos Vingopoulos; Rongrong Le; Inês Laíns; David M Wu; Dean Eliott; Demetrios G Vavvas; Deeba Husain; Joan W Miller; Leo A Kim; John B Miller
Journal:  Br J Ophthalmol       Date:  2020-06-26       Impact factor: 5.908

6.  Effect of vessel enhancement filters on the repeatability of measurements obtained from widefield swept-source optical coherence tomography angiography.

Authors:  Jimmy Hong; Mengyuan Ke; Bingyao Tan; Amanda Lau; Damon Wong; Xinwen Yao; Xinyu Liu; Leopold Schmetterer; Jacqueline Chua
Journal:  Sci Rep       Date:  2020-12-17       Impact factor: 4.379

7.  A Comparative Study of Macular and Choroidal Thickness and Blood-Flow Parameters in Patients with Intermediate and Simple Juvenile Moderate Myopia.

Authors:  TaiNan Lin; Yan Yang; JinHua Lin; JiHui Zhang; Qian Wen; XiaoLu He; GuoQing Chen
Journal:  Int J Gen Med       Date:  2021-04-16

Review 8.  Optical coherence tomography angiography in the management of diabetic retinopathy.

Authors:  Enrico Borrelli; Riccardo Sacconi; Giuseppe Querques; Francesco Bandello
Journal:  Indian J Ophthalmol       Date:  2021-11       Impact factor: 1.848

9.  Identification of key lipid metabolites during metabolic dysregulation in the diabetic retinopathy disease mouse model and efficacy of Keluoxin capsule using an UHPLC-MS-based non-targeted lipidomics approach.

Authors:  Nan Ge; Ling Kong; Ai-Hua Zhang; Ye Sun; Man-Qian Zhao; Bo Zhang; Lei Xu; Xiao Ke; Hui Sun; Xi-Jun Wang
Journal:  RSC Adv       Date:  2021-02-01       Impact factor: 3.361

10.  Assessment of Artifacts in Swept-Source Optical Coherence Tomography Angiography for Glaucomatous and Normal Eyes.

Authors:  Weijing Cheng; Yunhe Song; Fengbin Lin; Jian Xiong; Fei Li; Ling Jin; Zhenyu Wang; Chunman Yang; Bin Yang; Fanyin Wang; Guili Ning; Wei Wang; Xiulan Zhang
Journal:  Transl Vis Sci Technol       Date:  2022-01-03       Impact factor: 3.283

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.